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ABSTRACT OF THE DISSERTATION 
 
Effects of Toxoplasma gondii Infection on NK Cells and ILC1s  
by 
Eugene Park 
Doctor of Philosophy in Biology and Biomedical Sciences 
Immunology 
Washington University in St. Louis, 2020 
Professor Wayne Yokoyama, Chair 
Natural killer cells and Type I innate lymphoid cells (ILCs) are subsets of ILCs. In C57BL/6 
mice, they share expression of the surface markers NK1.1 and NKp46, and can produce the 
cytokine interferon-g. These similarities led to the initial classification of natural killer cells and 
Type I ILCs together under the category of Group 1 ILCs. However, more recent studies found 
that natural killer cells and ILC1s develop from distinct progenitor cells and utilize transcription 
factor in distinct manners. Whereas ILC1s require Tbet for their development and are Eomes-
independent, natural killer cells require Tbet only for terminal maturation and are Eomes-
dependent. As such, these populations were reclassified as separate ILC subsets. In the context of 
Toxoplasma gondii infection, we identified a new population that blurs these strict delineations. 
Our data suggest that T. gondii induces the development of ILC1-like cells that primarily result 
from the downregulation of Eomes and the upregulation of Tbet. We further validated these 
findings with epigenomic profiling and single-cell RNA sequencing. 
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Chapter 1: Introduction 
1.1 Conventional Natural Killer Cells 
Conventional natural killer (cNK) cells are innate cells, relying on signals through germline-
encoded receptors to discern healthy cells from infected or transformed cells. Although cNK 
cells develop from the common lymphoid progenitor (CLP), like B and T lymphocytes, they are 
unique in being effective without priming, possessing preformed granules containing perforin 
and granzymes. This allows cNK cells to mount swift responses early in infection, keeping 
pathogens at bay while adaptive immune cells activate and expand (Yokoyama, 2013). 
 
Conventionally, cNK cells arise from CLPs in the bone marrow (Rosmaraki et al., 2001). This 
process relies on IL-15 (Kennedy et al., 2000), which induces expression of transcription factors 
that regulate cNK cell development. Among these transcription factors are Ets-1, Pu.1, and Id2, 
which are shared across multiple hematopoietic lineages. In contrast, Nfil3 uniquely specifies the 
cNK cell lineage, as revealed by Nfil3-deficient mice, which lack peripheral cNK cells but 
maintain normal numbers of other immune cell types (Gascoyne et al., 2009). In addition, Tbet 
deficiency results in arrested cNK cell maturation and reduction of peripheral cNK cells (Gordon 
et al., 2012; Townsend et al., 2004). Eomesodermin (Eomes), like Tbet, is a T-box transcription 
factor that drives cNK cell development, and the deletion of Eomes within the lymphoid lineage 




In addition to transcription factor expression, the canonical model of cNK cell development also 
corresponds to the expression of surface markers. Early in development, cNK cells gain 
expression of NK1.1 (in C57BL/6 mice) and various activating and inhibitory receptors (Kim et 
al., 2002). Terminally mature cNK cells express the a2 integrin (i.e. CD49b/DX5). Additionally, 
cNK cell maturation can be followed based on expression of CD27 and CD11b, where cNK cells 
begin as double-negative, and progress through CD27+ CD11b–, CD27+ CD11b+, and CD27– 
CD11b+ stages as they differentiate (Chiossone et al., 2009). 
 
For many years the major focus of cNK cell studies has been on their roles during early immune 
processes. In Murine cytomegalovirus (MCMV) infection, cNK cells target infected cells 
through the interaction between the activating NK cell receptor Ly49H and the viral protein 
m157 expressed on the surface of infected cells (Arase et al., 2002; Brown et al., 2001; Smith et 
al., 2002). cNK cells can also lyse tumor cells due to their recognition of "missing self," wherein 
inhibitory receptors lose inhibitory signaling when their ligands are downregulated on target 
cells. 
 
cNK cell activity is usually insufficient for complete control of viral infection or tumorigenesis, 
and collaboration with adaptive lymphocytes is often required. In MCMV infection, for instance, 
infection of Rag1-/- mice, in which cNK cells are intact but adaptive lymphocytes are absent, 
leads to recrudescence of infection due to mutations in MCMV that allow for evasion of cNK 
cell recognition (French et al., 2004). Thus, development of an adaptive immune response is 
necessary for identification of escape mutants and viral elimination, exemplifying the principle 
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that cNK cells are critical early in immune processes, while adaptive lymphocytes are often 
required during later responses. However, cNK cells may also contribute to late immune 
responses and though this possibility remains largely unexplored. 
1.2  NK Cell Memory 
cNK cells were once thought to become activated in response to stimuli and return to a basal 
resting state after stimulation subsides. However, recent studies have shown that cNK cells can 
adopt long-lasting alterations that accompany functional changes. Whereas initial study of 
MCMV infection focused on the role of cNK cells during the first week of infection (Arase et al., 
2002; Brown et al., 2001; Smith et al., 2002), more recently, studies have expounded upon these 
findings to unearth adaptations that cNK cells undertake even after MCMV clearance. Following 
clonal expansion and contraction of Ly49H+ cNK cells, MCMV-experienced Ly49H+ cNK cells 
persist, rapidly expand upon challenge, and confer better protection compared to naïve cNK cells 
(Sun et al., 2009a). IL-12 signaling during acute infection is thought to be crucial in endowing 
cNK cells with the capacity for memory (Sun et al., 2012). 
 
Phenotypically, MCMV-induced memory cNK cells resemble naïve cNK cells. Examination of 
cNK cells at various time points post-infection by microarray showed that memory cNK cells 
have very few transcriptional changes, relative to the Ly49H+ effector cNK cells at 7 dpi. Indeed, 
when Ly49H+ cNK cells were adoptively transferred from wild-type mice into Ly49H-deficient 
recipients, challenged with MCMV, and sorted for microarray 27 dpi, CD49a, Ly6C, and CD11b 
were the only differentially expressed surface markers (Bezman et al., 2012). However, subtle 
transcriptional differences belied indelible imprints on the chromatin landscape. Analysis of 
memory cNK cells by the assay by the assay for accessibility for transposase-accessible 
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chromatin using sequencing (ATAC-seq) showed unique patterns of chromatin accessibility in 
memory cNK cells, some of which bear semblance to those of memory CD8+ T cells (Lau et al., 
2018). Motif binding analysis also showed enrichment of distinct transcription factor binding 
sites in differentially accessible regions, and in particular, loss of NK-kb binding motifs in 
memory cNK cells. 
 
In humans, clonal expansion of cNK cell is thought to occur following Human cytomegalovirus 
(HCMV) infection, as HCMV seropositivity correlates with an increased frequency of NKG2C+ 
cNK cells (Guma et al., 2004; Guma et al., 2006). In these individuals, NKG2C+ cNK cells often 
have additional distinctions, such as lack of FcRg and alterations in signaling molecules. Like 
MCMV-induced memory cNK cells in mice, these FcRg– NK cells (g–NK cells) have striking 
differences in chromatin accessibility and DNA methylation, which correspond to transcriptional 
differences (Lee et al., 2015; Schlums et al., 2015). Functionally, these memory-like cNK cells 
display enhanced expansion in the presence of HCMV infected cells and autologous plasma, 
compared to FcRg+ NK cells, suggesting these cNK cells may confer protection in conjunction 
with antibodies. 
 
An in vitro corollary of memory NK cells shows that pre-activation of cNK cells with IL-12 and 
IL-18 results in the development of memory-like NK cells, which are long-lived and possess an 
enhanced ability to produce IFNg even months later (Cooper et al., 2009). This finding has been 
mirrored in recent studies in humans that showed that pre-activation with cytokines resulted in 
enhanced tumoricidal capacity and therapeutic benefits in patients with acute myeloid leukemia 
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(Romee et al., 2016; Romee et al., 2012). Both MCMV-induced memory NK cells and cytokine-
induced memory-like NK cells require IL-12 signaling to adapt long-lasting functional changes 
(Sun et al., 2012). 
1.3  NK Cell Heterogeneity 
Interestingly, examination of cNK cells under steady state conditions does not always predict 
behavior under stimulation. For instance, cNK cell developmental requirements change during 
MCMV. Whereas IL-15 signaling through IL-15 receptor is required for cNK cell development 
in steady state, it may be dispensable during MCMV infection as Ly49H+ NK cells expand in 
Il15ra-/-, Il15-/-, and Rag2-/- Il2rg-/- mice (Sun et al., 2009b). Moreover, while Nfil3 is normally 
required for development of cNK cells, Ly49H+ NK cells expand in Nfil3-deficient mice during 
MCMV infection (Firth et al., 2013). Lastly, inducible deletion of Tbet and Eomes reveal 
differing roles of these T-box transcription factors as well. Whereas Eomes is required for NK 
cell development, its deletion only impairs expansion during acute MCMV infection, but does 
not affect naïve or memory NK cell maintenance. On the other hand, Tbet was found to be 
required for both NK cell expansion during MCMV infection, as well as memory NK cell 
maintenance at later time points (Madera et al., 2018). 
 
Additional instances of NK cell heterogeneity have been uncovered under steady state 
conditions. The majority of NK cells circulate through the bloodstream and these circulating 
cNK cells were once considered the predominant NK cell population. However, parabiosis 
studies have shown there are additional tissue-restricted populations that differ in their phenotype 
and transcription factor dependence. Under steady state conditions, DX5 and CD49a expression 
is mutually exclusive and denotes circulating and tissue-resident NK cells, respectively (Peng et 
6 
 
al., 2013). Populations of tissue-resident NK cells exist in the salivary gland and uterus, where 
they outnumber cNK cells (Cortez et al., 2016). Interestingly, these populations are Nfil3-
independent, unlike cNK cells (Cortez et al., 2014; Sojka et al., 2014). 
1.4  Innate Lymphoid Cells 
NK cells were once thought to be the predominant innate lymphocyte population. However, in 
the last decade, additional innate lymphocyte subsets that also develop independently of antigen 
receptor rearrangement and are present in Rag-deficient mice have been identified. These 
additional innate lymphocyte populations widely differ in development, phenotype, and 
distribution. Their discovery has resulted in reframing cNK cells within the broader context of 
innate lymphoid cells (ILCs). 
 
Apart from cNK cells, ILCs display tissue-residency within mucosal sites and require signaling 
through the IL-7 receptor for development. Initially, ILCs were classified into three major 
categories based on their cytokine production and transcription factor dependence, which 
mirrored CD4+ T cell subsets (Spits et al., 2013). Group 1 ILCs encompassed NK cells and 
ILC1s, which both produce IFNg. Group 2 were defined as cells that produce IL-5 and IL-13. 
Group 3 ILCs encompassed lymphoid tissue inducer (LTi) cells and ILC3s, which could produce 
IL-17 or IL-22. These distinct cytokine production profiles are thought to underlie distinct 
functionality of these cells, which occupy different tissues and are thought to be specialized for 
their own microenvironments. 
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1.5  Comparison of NK Cells and Type I ILCs 
NK cells and ILC1s were once classified together as Group 1 ILCs because they express Tbet, 
produce IFNg, and identifiable based on co-expression of NK1.1 and NKp46. However, they 
were recently reorganized as distinct subpopulations of ILCs, owing to recent observations that 
their developmental paths diverge downstream of the CLP (Vivier et al., 2018). NK cells develop 
from the NK Precursor (NKP) while other ILCs arise from the common helper ILC precursor 
which further differentiates into the ILC precursor (ILCp) (Constantinides et al., 2014; Klose et 
al., 2014; Rosmaraki et al., 2001). In contrast to NK cells, ILC1s are entirely Tbet-dependent and 
develop uninterrupted in the absence of Eomes (Daussy et al., 2014; Sojka et al., 2014). 
 
In additional to developmental differences, NK cells and ILC1s are found at distinct anatomical 
sites. ILC1s are thought to be tissue-resident, as parabiosis studies show they are retained within 
organs such the liver and small intestine without recirculating (Gasteiger et al., 2015; Sojka et 
al., 2014). Like tissue-resident NK cells, ILC1s express CD49a. In addition, ILC1s can produce 
TNFα in addition to IFNg, while NK cells only produce IFNg. 
 
The function of ILC1s remains unclear, but work thus far has focused on their contributions in 
clearing acute infection and limiting tumor formation, much like cNK cells. Like cNK cells, T 
cell receptor expressing ILC1-like cells can lyse tumor cells through the release of cytotoxic 
granules (Dadi et al., 2016). Moreover, in MCMV infection, liver ILC1s have the potential to 
limit early viral spread by producing IFNg (Weizman et al., 2017). Furthermore, in Toxoplasma 
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gondii infection, both cNK cells and ILC1s produce IFNg to stimulate inflammation (Goldszmid 
et al., 2012; Klose et al., 2014). 
1.6  NK Cells and ILC1s in Toxoplasma gondii Infection 
Toxoplasma gondii is an intracellular parasite that infects a third of the global population 
(Montoya and Liesenfeld, 2004). Its definitive hosts are cats, which can transmit infectious T. 
gondii oocysts through their feces into the environment (Dubey and Frenkel, 1972). These 
oocysts are resistant to environmental conditions and can persist for long periods of time. Most 
warm-blooded animals are susceptible to infection and can become infected by consuming 
infected foods. After entering hosts via the digestive tract, T. gondii differentiates into rapidly 
replicating tachyzoites that disseminate systemically (Hunter and Sibley, 2012). 
 
Upon recognition of the parasite, dendritic cells produce IL-12. This cytokine subsequently 
stimulates cNK cells to produce IFNγ and ILC1s to produce IFNg and TNFa (Goldszmid et al., 
2012; Klose et al., 2014). A strong adaptive response correlates with the clearance of acute 
infection, and mounting immune pressure eventually causes tachyzoites to differentiate into 
slowly replicating bradyzoites. The presence of bradyzoites, which are primarily encysted within 
cells of the central nervous system and skeletal muscle, marks the chronic phase of T. gondii 




Chapter 2: Characterization of  
NK Cells and ILC1s in 
T. gondii Infection 
2.1 Protective Effects 
Previous analysis of the impact of NK cells in the protection of C57BL/6 mice during infection 
with T. gondii relied on depletion of NK cells using α-asialoGM1 (Goldszmid et al., 2007), 
which depletes not only NK cells but also basophils (Nishikado et al., 2011). To eliminate 
NK1.1-expressing cells specifically, i.e. NK cells and ILC1s, we administered α-NK1.1 to 
C57BL/6 mice prior to i.p. (intraperitoneal) infection with 200 tachyzoites of the type II 
Prugniaud (Pru) strain of T. gondii. We used a luciferase-expressing strain, PRU-FLuc-GFP, 
which allowed for monitoring of parasites in vivo. We observed that infection resulted in 
increased parasite load in mice treated with α-NK1.1 at 6 dpi (Figure 1). Moreover, half of the α-
NK1.1-treated mice died 10-15 dpi (Figure 2), consistent with previous reports. 
2.2 Phenotype of Splenic Cells 
The acute phase of Type II T. gondii infection in C57BL/6 mice subsides by 3-4 weeks post-
infection. Around the same time, adaptive immune cells become activated and CD8+ T cells 
become major producers of IFNg. Additionally, NK cells can be depleted 3 wk post-infection 
without causing increased mortality (data not shown). Regardless, we observed changes among 
NK1.1+ NKp46+ cells that were maintained even at later time points, suggesting ongoing 
activation or long-lasting alterations to NK cell homeostasis. We assessed the effect of T. gondii 
infection on NK1.1+ NKp46+ populations by following expression of Eomes and CD49a, as cNK 
cells express Eomes and not CD49a, whereas ILC1s do not express Eomes but do express 
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CD49a. In the spleen under steady state conditions, Eomes+ CD49a– cNK cells comprise the 
majority of NK1.1+ NKp46+ cells, while 2-3% are Eomes– CD49a+, which is the phenotype of 
ILC1s (Figure 3). Interestingly, over the course of infection, cNK cells decreased both as a 
proportion of NK1.1+ NKp46+ cells and in absolute number. By contrast, beginning at 21 dpi, 
there was an increase in Eomes– CD49a+ ILC1s. Interestingly, which acute T. gondii infection 
unusually resolves within 3-4 weeks, we observed increased numbers of T. gondii-induced ILC1s 
even 4 months post-infection (Figure 4) 
 
The expansion of ILC1-like cells may be due to T. gondii-induced expansion of preexisting 
ILC1s. However, it is also possible that infection induces a novel ILC1-like population, or that 
the ILC1-like cells are heterogeneous and comprise multiple subpopulations. We further 
compared the cNK cells and ILC1s in uninfected and mice infected 35 d earlier to determine if 
differences existed between the ILC1s in uninfected and infected mice. In terms of the 
maturation markers CD27 and CD11b, the cNK cells in both uninfected and infected mice were 
distributed across CD27+ CD11b–, CD27+ CD11b+, and CD27– CD11b+ stages, while ILC1s 
were predominantly CD27+ CD11b–, as previously reported (Chiossone et al., 2009; Sojka et al., 
2014). Surprisingly, the ILC1s in uninfected mice were predominantly CD27– CD11b+, with a 
smaller frequency of CD27+ CD11b– cells (Figure 5). 
 
Flow cytometric analysis also showed that ILC1s from the spleens of infected mice expressed 
Neuropilin-1 and KLRG1 at higher levels than the other populations, and DNAM-1 and NKG2A 
more highly than cNK cells (Figure 6). We next assessed expression of Ly49 receptors. We 
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found that similar to the ILC1s in uninfected mice, the ILC1s from infected mice expressed most 
canonical NK receptors at lower frequencies than cNK cells (Figure 7). Moreover, there were 
minor alterations of Ly49 receptor expression between the cNK cells in uninfected and infected 
mice, suggesting that T. gondii infection may alter the antigen recognition properties of NK cells 
and perhaps cause expansion of certain subpopulations.  
 
To further compare these populations, we assessed their ability to produce cytokines. Following 
stimulation with IL-12, IL-12 + IL-18, or PMA + Ionomycin, we found that all populations were 
able to produce IFNg (Figure 8A). Interestingly, higher frequencies of cNK cells from infected 
mice produced IFNg following stimulation. We also assessed TNFα production following PMA 
+ Ionomycin stimulation, which is a hallmark of ILC1s. Whereas ILC1s in uninfected mice 
produced TNFα, the ILC1s in infected mice did not (Figure 8B). 
2.3 RNA Sequencing Analysis 
To understand how T. gondii infection shapes NK1.1+ NKp46+ populations in greater depth, we 
performed RNA-sequencing (RNA-seq) of the predominant NK1.1+ NKp46+ populations in the 
uninfected and infected spleen: cNK cells from uninfected mice and cNK cells and T. gondii-
induced ILC1s from infected mice. We found that Ly6C is not expressed by most ILC1s that are 
already present in the uninfected spleen, but highly expressed by ILC1s following infection 
(Figure 9). For RNA-seq analysis, we identified cNK cells as CD49a– Ly6C– cells, which 
expressed Eomes. Meanwhile, we identified T. gondii-induced ILC1s as CD49a+ Ly6C+ cells, 
which accurately identified Eomes– cells (Figure 10). Principal component analysis and 
hierarchical clustering showed a higher degree of similarity between cNK cells from uninfected 
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and infected mice, relative to the T. gondii-induced ILC1s, which displayed more variability 
(Figure 11A-B). As expected, Ly6c1, Ly6c2, Itga1, and Eomes were differentially expressed 
(Figure 11C). 
 
The small number of splenic CD49a+ ILC1s in uninfected mice precluded the possibility of 
RNA-seq of this specific population. Instead, we performed gene set enrichment analysis 
(GSEA) with previously published lists of signature ILC1 genes to determine if T. gondii-
induced ILC1s possessed core ILC1 traits (Robinette et al., 2015). An ILC1 signature was indeed 
enriched in T. gondii-induced ILC1s relative to cNK cells from infected mice (Figure 12A), with 
17 of 53 signature ILC1 genes expressed at higher levels, including Itga1 and Cxcr6 (Table 1). 
Consistently, T. gondii-induced ILC1s also expressed 14 of 35 signature cNK cell genes at lower 
levels compared to cNK cells, including Eomes (Figure 12B, Table 2). However, T. gondii-
induced ILC1s expressed lower levels of the signature ILC1 gene Tmem154 and higher levels of 
the signature cNK cell genes Gpx8, Klrg1, and Cdc20b. Thus, T. gondii-induced ILC1s were 
enriched for the ILC1 signature, but also expressed cNK cell genes, incompletely recapitulating 
all aspects of either cell type. Overall, the data suggest that T. gondii-induced ILC1s possess 
some characteristics of both cNK cells and ILC1s, but also display unique features. 
 
T. gondii-induced ILC1s differed from both cNK cells and steady state ILC1s in their expression 
of surface markers, transcription factors, secreted factors, adhesion molecules, chemokine 
receptors, signaling molecules, and NK cell receptors (Figure 13), which the transcriptional 
profile verifying our flow cytometric analysis above (Figures 6-7). In addition, we observed 
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striking differences in the expression patterns of transcription factors such as increased 
expression of Foxn3, Rbpj, and Tbx21 and decreased expression of Nfkb1, Tox, and Batf3 in T. 
gondii-induced ILC1s relative to cNK cells. Cytokine receptor expression also differed, with T. 
gondii-induced ILC1s expressing higher levels of Tgfbr2, Il2ra, and Il7ra. Together these 
findings suggested the T. gondii-induced ILC1s may have unique developmental requirements, 
as compared to cNK cells. 
2.4 Anatomical Distribution 
In addition to expressing the tissue-residency marker CD49a, T. gondii-induced ILC1s expressed 
high levels of Zfp683 (Figure 13), a transcription factor that programs tissue-residency (Mackay 
et al., 2016). GSEA revealed enrichment of tissue-residency genes (Milner et al., 2017) among 
genes expressed more highly by T. gondii-induced ILC1s (Figure 14A, Table 3). However, genes 
comprising a circulatory signature were not lost (Figure 14B, Table 4). Moreover, RNA-seq 
showed that T. gondii-induced ILC1s differentially expressed chemokine receptors and adhesion 
molecules compared to cNK cells and ILC1s from uninfected mice (Figure 13). Flow cytometric 
analysis verified that ILC1s from infected mice expressed CX3CR1, CCR8, CXCR6, and 
PECAM-1 and did not express CD62L (Figure 15). These features suggested that T. gondii-
induced ILC1s may exhibit distinct patterns of distribution or migration as compared to cNK 
cells and steady state ILC1s. 
 
In contrast to ILC1s in uninfected mice, ILC1s were increased in the blood of infected mice, 
indicating that these cells circulate (Figure 16). Consistently, ILC1s were also increased in the 
spleen and lung. However, they were unaltered or decreased in the mesenteric lymph node, brain, 
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peritoneum, bone marrow, uterus, and salivary gland (Figure 17). In the liver, the frequency of 
ILC1s did not increase (Figure 16), but this was possibly confounded by a sizeable ILC1 
population already present at steady state (Peng et al., 2013; Sojka et al., 2014). To assess this in 
further depth, we examined expression of Ly6C, which is not expressed in the liver under state 
conditions but is expressed by ILC1s following T. gondii infection. Indeed we found that Ly6C 
was expressed by approximately half of the ILC1s from livers of infected mice, as well as by 
ILC1s in the blood and lungs of infected mice (Figure 18). Accordingly, the number of Ly6C+ 
ILC1s was increased relative to uninfected mice, while the number of Ly6C– ILC1s was 
comparable, which suggested that some of the ILC1s that are present during steady state remain 
unchanged by T. gondii infection.  
 
To compare homing of NK cells and ILC1s cells from infected mice, we isolated Eomes-GFP+ 
CD49a– and Eomes-GFP– CD49a+ cells from congenically distinct infected Eomes-GFP mice for 
adoptive transfer into naïve Rag2-/- Il2rg-/- mice (). When we assessed the recipient mice 24 days 
later, we detected both populations in the spleen and liver (Figure 19). Although cNK cells 
upregulated CD49a upon transfer into Rag2-/- Il2rg-/- mice, as previously reported (Gao et al., 
2017), the Eomes expression generally remained the same, suggesting that T. gondii-induced 
ILC1s may persist independent of infection. Interestingly, while the percentage of transferred 
ILC1s was higher than transferred cNK cells in the spleen, this percentage was even more 
skewed in the liver, where ILC1s comprised nearly all transferred cells, suggesting their homing 
pattern may be altered, even though they circulate in the blood. Nonetheless, overall our data 
indicated that T. gondii induced a population of circulating ILC1s. 
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2.5 Epigenomic Analysis 
Chromatin accessibility patterns differ in cNK cells and ILC1s (Shih et al., 2016), and infection 
can induce long-lasting epigenetic changes in cNK cells (Lau et al., 2018). To determine if T. 
gondii-induced ILC1s possess a stable chromatin landscape that is distinct from that of cNK 
cells, we performed ATAC-seq (Buenrostro et al., 2015), comparing splenic cNK cells from 
uninfected mice and cNK cells and T. gondii-induced ILC1s from infected mice. As in the RNA-
seq analysis, the accessibility pattern of T. gondii-induced ILC1s was distinct from that of the 
cNK cell populations in naïve and infected mice, which more closely resembled each other 
(Figures 20A-B). The majority of differentially accessible regulatory elements (REs) were within 
introns or intergenic regions (Figure 20C), consistent with categorization as putative enhancers. 
These findings suggested that T. gondii-induced ILC1s are a discrete and stable population. To 
determine if ILC1 epigenetic features accounted for differences, we referred to published ATAC-
seq data of liver cNK cells and ILC1s (Shih et al., 2016). Indeed, the Eomes locus was less 
accessible in T. gondii-induced ILC1s than cNK cells, and resembled the Eomes locus of ILC1s 
in uninfected mice (Figure 21A). However, T. gondii-induced ILC1s displayed increased 
accessibility of an NK cell-specific enhancer in the Tbx21 locus, which was inaccessible in 
ILC1s (Figure 21B). 
 
We organized differentially accessible REs into a non-redundant peak set containing 6 clusters 
(Figure 22A). Clusters 1, 3, and 5 contained REs that were uniquely more accessible in 
uninfected cNK cells, cNK cells from infected mice, and T. gondii-induced ILC1s, respectively. 
Clusters 2, 4, and 6 contained REs that were shared between two groups. Cluster 2 encompassed 
REs that were more accessible in both cNK cell groups relative to T. gondii-induced ILC1s, and 
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accounted for the largest fraction of peaks, showing that cNK cells share many epigenetic 
features regardless of infection. Somewhat surprisingly, Cluster 4, which contained REs that 
were more accessible in both cNK cells and T. gondii-induced ILC1s from infected mice relative 
to uninfected cNK cells, was the second largest cluster, suggesting that infection induces 
epigenetic changes, some of which are common to both populations. 
 
We also sought to identify additional differences between cNK cells and T. gondii-induced 
ILC1s following infection by directly comparing the REs in Clusters 3 and 5. Analysis of 
transcription factor binding motifs revealed motifs that were significantly enriched in each 
population, such as NF-kb in Cluster 3, whose motif was present in 13.2% of REs, and Klf4 in 
Cluster 5, whose motif was present in 25.8% of REs (Figure 22B). Enriched motifs were found 
within a differentially accessible REs in the Tbx21 locus shown above (Figure 21B). We also 
identified the specific loci that contained the most differentially accessible REs (Figure 23A). 
Generally, the presence of more accessible REs correlated with greater gene expression. Notably, 
many of the epigenetic features shared by memory NK cells and memory CD8+ T cells (Lau et 
al., 2018) were among the loci that gained accessibility in T. gondii-induced ILC1s as compared 




Figure 1: Effect of α-NK1.1 treatment on T. gondii parasite burden 
 
(A) Representative images of luciferase imaging of undepleted mice and α-NK1.1-treated mice 
lying supine, at indicated time points after i.p. infection with 200 Pru.Luc T. gondii parasites. 
(B) Total photon flux at indicated time points after infection (n=5; mean±SEM; unpaired t-test, *p 
£ 0.05).  
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Figure 2: Effect of α-NK1.1 treatment on survival following T. gondii infection 
 
Percentage of mice surviving at indicated time points after i.p. infection with 200 T. gondii 
tachyzoites Pru strain (n=10; Mantel-Cox test; *p £ 0.01).  



















Figure 3: Quantification of cNK cells and ILC1s after T. gondii infection 
 
(A) Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from spleens of 
uninfected mice and mice at indicated time points after i.p. infection with 200 tachyzoites of 
T. gondii Pru strain. 
(B) Frequency and absolute number of CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a– and CD3– 
CD19– NK1.1+ NKp46+ Eomes– CD49a+ cells from spleens of uninfected mice and mice at 
indicated time points after infection (n=5; mean+SEM; one-way ANOVA with Bonferroni 




Figure 4: Quantification of cNK cells and ILC1s 4 months after T. gondii infection 
 
(A) Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from spleens of 
uninfected mice and mice 4 mo after i.p. infection with 200 tachyzoites of T. gondii Pru strain. 
(B) Frequency (of CD3– CD19– NK1.1+ NKp46+ cells) and absolute number of cNK (Eomes+ 
CD49a–) and ILC1s (Eomes– CD49a+) from spleens of uninfected mice and mice 4 mo post-
infection (n=5; mean+SEM; one-way ANOVA with Bonferroni correction, *p £ 0.05, ***p £ 




Figure 5: Expression of cNK cell maturation markers 
 
Expression of CD27 and CD11b by cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a–) 
and ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from spleens of uninfected mice and 
mice infected 35 d earlier by i.p. injection of 200 tachyzoites of T. gondii Pru strain (n=3-5, 
mean+SEM; one-way ANOVA with Bonferroni correction, *p £ 0.05, **p £ 0.01, ***p £ 0.001, 






Figure 6: Surface markers differentially expressed by cNK cells and ILC1s 
 
Expression of Neuropilin-1, KLRG1, DNAM-1, and NKG2A by cNK cells (CD3– CD19– NK1.1+ 
NKp46+ Eomes+ CD49a–) and ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from 





Figure 7: Expression of Ly49 receptors 
 
Expression of indicated Ly49 receptor by cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ 
CD49a–) and ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from spleens of uninfected 




Figure 8: Cytokine production by cNK cells and ILC1s 
 
(A) Intracellular IFNg after 4 hr of culture in media alone (unstim), or media supplemented with 
IL-12, IL-12 + IL-18, or PMA + Ionomycin (P+I) in cNK cells (CD3– CD19– NK1.1+ NKp46+ 
Eomes+ CD49a+) and ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from spleens 
of uninfected and mice infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain. 
(B) Intracellular TNFα in cNK cells and ILC1s after 4 hr of culture in media alone (unstim), or 
media supplemented with P+I (n=3; mean+SEM; one-way ANOVA with Bonferroni’s 





Figure 9: Expression of Ly6C by cNK cells and ILC1s 
 
(A) Expression of Ly6C by cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a–) and ILC1s 
(CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from the spleens of uninfected mice and 
mice at indicated time points after infection with T. gondii Pru strain. 
(B) Frequency of cNK cells and ILC1s expressing Ly6C at indicated time points post-infection 





Figure 10: Gating strategy to sort cNK cells and T. gondii-induced ILC1s 
 
(A) Sorting strategy to isolate splenic cNK cells from uninfected mice and cNK cells and T. 
gondii-induced ILC1s from mice infected 35 d earlier with 200 tachyzoites of T. gondii Pru 
strain (gated on CD3– CD19– NK1.1+ NKp46+). 





Figure 11: RNA-seq of cNK cells and ILC1s from T. gondii-infected mice 
 
(A) Principal component analysis using top 2000 most variable genes comparing splenic cNK 
cells from uninfected mice (n=3), and cNK cells and T. gondii-induced ILC1s from mice 
infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain (n=5). Points represent 
biological replicates. 
(B) Unsupervised hierarchical clustering of samples in (A). 
(C) Volcano plots showing Log2(Fold Change) (FC) differences versus -Log10(False Discovery 
Rate) (FDR) for indicated comparisons. Genes exhibiting Log2FC > 1 and False Discovery 

























































































































































Figure 12: Gene Set Enrichment Analysis for signature ILC1 and NK cell genes 
 
GSEA of signature (A) ILC1 and (B) NK cell genes (Robinette et al., 2015), using genes ranked 
by DESeq2 Wald statistic of T. gondii-induced ILC1s relative to cNK cells from mice infected 35 
d earlier with 200 tachyzoites of T. gondii Pru strain. 
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Figure 13: Heatmaps of differentially expressed genes 
 
Heatmaps showing centered DESeq2 variance-stabilized expression values of manually selected 
genes exhibiting Log2FC > 1 and FDR < 0.1 by cNK from uninfected mice and cNK cells and T. 


















































































































































































Figure 14: Gene Set Enrichment Analysis for signature genes of tissue-residency and circulation 
 
GSEA of signature (A) tissue-residency and (B) circulation genes (Milner et al., 2017), using genes 
ranked by DESeq2 Wald statistic of T. gondii-induced ILC1s relative to cNK cells from mice 




Figure 15: Expression of chemokine receptors and adhesion molecules 
 
Expression of CX3CR1, CCR8, CXCR6, PECAM-1, and CD62L by cNK cells (CD3– CD19– 
NK1.1+ NKp46+ Eomes+ CD49a–) and ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) 
from spleens of uninfected mice and mice infected 35 d earlier with 200 tachyzoites of T. gondii 
Pru strain (n=3-5, mean+SEM; one-way ANOVA with Bonferroni correction, **p £ 0.01, ***p £ 





Figure 16: T. gondii-induced ILC1s in additional organs 
 
(A) Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from the blood, lung, 
and liver of uninfected mice and mice infected 35 d earlier with 200 tachyzoites of T. gondii 
Pru strain. 
(B) Frequency of ILC1s (Eomes– CD49a+) among CD3– CD19– NK1.1+ NKp46+ cells in indicated 
organs from uninfected and infected mice (n=3-5, mean+SEM; one-way ANOVA with 
Bonferroni correction, ns not significant, ***p £ 0.001, ****p £ 0.0001). 
(C) Absolute number of ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from the blood, 





Figure 17: Organs that do not increase in T. gondii-induced ILC1s 
 
(A) Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from indicated organs 
of uninfected mice and mice infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain. 
(B) Absolute number of ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from indicated 
organs of uninfected mice and infected mice (n=3-5, mean+SEM; unpaired t-test, ns not 





Figure 18: Ly6C expression by ILC1s in T. gondii-infected mice 
 
(A) Expression of Ly6C by ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from the liver 
of uninfected mice and mice infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain. 
(B) Frequency of liver ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) expressing Ly6C, 
and absolute number of Ly6C+ ILC1s and Ly6C– ILC1s in the liver (n=3-5, mean+SEM; 





Figure 19: Homing of NK cells and ILC1s in lymphopenic recipients 
 
(A) Overview of competitive transfer experiment. NK cells and ILC1s were sorted from day 35-
infected CD45.2 and CD45.1 x CD45.2 Eomes-GFP reporter mice, respectively. Cells were 
combined in a 1:1 ratio and intravenously injected into Rag2-/- Il2rg-/- mice. Twenty-four days 
later, the recipient spleen and liver were assessed for transferred cells. 
(B) Expression of CD45.1 and CD45.2 by CD3– CD19– NK1.1+ NKp46+ cells from the spleen 
and liver of Rag2-/- Il2rg-/- mice, and frequency of transferred Eomes-GFP+ CD49a– cells 
(CD45.2+) and Eomes– CD49a+ cells (CD45.1+ CD45.2+), 24 days after transfer (n=5, 
mean+SEM; two-way ANOVA, ***p £ 0.001). 
(C) Expression of CD49a and Eomes-GFP by transferred NK cells and transferred Eomes-GFP– 
CD49a+ cells and frequency of Eomes– CD49a+ cells within each population, 24 days post-




Figure 20: Epigenomic Differences in cNK cells and T. gondii-induced ILC1s  
 
(A) Unsupervised principal component analysis comparing splenic cNK cells from uninfected 
mice, and cNK cells and T. gondii-induced ILC1s from mice infected 35 d earlier with 200 
tachyzoites of T. gondii Pru strain (n=3). Points represent biological replicates. 
(B) Unsupervised hierarchical clustering of samples in (A). 
(C) Quantification of REs with log2FC>1 and FDR<0.05 within indicated genomic regions in 
pairwise comparison of cNK cells from infected mice versus cNK cells from uninfected mice 
(left), T. gondii-induced ILC1s and cNK cells from infected mice (middle), and T. gondii-


















































































































































































































Figure 21: Eomes and Tbx21 loci 
 
UCSC genome browser tracks showing ATAC-seq peaks in cNK cells from uninfected mice, and 
cNK cells and T. gondii-induced ILC1s from mice infected 35 d earlier with 200 tachyzoites of T. 
gondii Pru strain, and cNK cells and ILC1s from the liver of uninfected mice (Shih et al., 2016) at 
the (A) Eomes and (B) Tbx21 genomic loci. Differentially accessible regions between cNK cells 
and T. gondii-induced ILC1s from infected mice are highlighted in blue. Peach arrow denotes a 




Figure 22: Features of differential regulatory elements 
 
(A) Heatmap of REs that are differentially accessible in cNK cells and T. gondii-induced ILC1s, 
centered on peaks and showing 3 kb upstream and downstream of peak center. 
(B) De novo transcription factor binding motifs found enriched in Clusters 3 and 5 from (A), and 





Figure 23: Comparison of regulatory element accessibility and gene transcription 
 
For each gene listed, Log2FC of gene expression from RNA-seq is indicated by position of bottom 
point. Each differentially accessible RE is depicted as a point, with Log2FC of peak size in T. 
gondii-induced ILC1s, relative to cNK cells indicated by fill color of each point.  
(A) Loci containing the most differentially accessible REs. 
(B) Loci shared by MCMV-induced memory CD8+ T cells and NK cells (Lau et al., 2018).  













































































































































































































































































































































































































































Table 3: Signature tissue-residency gene set 
1700025G04Rik Fgf13 Pycard 
2010012O05Rik Flna Qprt 
3110052M02Rik Gab3 Rap1gap2 
A430078G23Rik Gm11435 Rasa3 
Acss1 Gramd4 Rasgrp2 
Aff3 Gzmm Rgs19 
Apobec2 Haao S1pr1 
Arhgap26 Icam2 S1pr4 
Arhgef18 Il17ra Samd3 
Armc7 Il18rap Sell 
As3mt Kbtbd11 Sfxn3 
Aven Kcnj8 Sh2d1a 
B3gnt5 Klf2 Sh3bp5 
Bin2 Klhdc1 Sidt1 
Car5b Klrb1c Sike1 
Cdc14b Klrg1 Slamf6 
Cmah Lair1 Smpdl3b 
D1Ertd622e Lfng Spn 
Dapl1 Limd1 St3gal1 
Dennd2d Lpin1 Stard10 
Dgka Ly9 Tcf7 
Dnahc8 Mboat1 Tlr1 
Dock5 Ms4a4c Tmem71 
Dusp7 Nck2 Tnfrsf26 
Ehd3 Nfatc3 Traf3ip3 
Elovl7 Nod1 Ubxn2b 
Eomes Nsg2 Usp33 
F2rl2 Pde2a Ypel1 
Fam49a Pion Zeb2 
Fam53b Prss12 Zfp595 




Table 4: Signature circulating gene set 
2900026A02Rik Egr1 Junb Rnf149 
AA467197 Ehd1 Kdm6b Rrad 
Abcb1b Ell2 Litaf Sik1 
Adam19 Fasl Lmnb1 Skil 
Atf3 Fbxo30 Ly6g5b Slc16a6 
B4galnt4 Fgl2 Mxd1 Slc7a5 
Bag3 Fmnl3 Mxi1 Spty2d1 
Bhlhe40 Fos Neurl3 Ssbp2 
Btg2 Fosl2 Nfil3 Stk17b 
Btg3 Gabarapl1 Nfkbie Tgif1 
Ccl4 Gadd45b Nr4a1 Tigit 
Cd244 Gem Nr4a2 Tiparp 
Cd69 Glrx Nr4a3 Tjp1 
Cdh1 Gpr171 Ntan1 Tnf 
Cdh7 Gpr56 Odc1 Tnfaip3 
Chn2 Gzmb P2ry10 Tnfrsf1b 
Cish H3f3b P4hb Tnfrsf9 
Coq10b Havcr2 Pdcd1 Tra2a 
Cpd Hip1 Per1 Trib1 
Crem Hpgds Plk3 Trp53inp2 
Ctla4 Hsp90aa1 Plscr1 Ube2s 
Dennd4a Hspa5 Pmepa1 Vps37b 
Dgat1 Icos Ppp1r15a Wsb1 
Dnaja1 Ifng Prdx6 Xcl1 
Dnaja4 Ifrd1 Ptp4a1 Zfand5 
Dnajb1 Il21r Qpct Zfp36l1 
Dnajb4 Il4ra Rbpj 
 
Dnajb6 Isg20 Rgs1 




Chapter 3: Development of 
T. gondii-Induced ILC1s 
3.1 Role of Ongoing Infection 
We postulated that the expansion of ILC1s following T. gondii infection was either a response to 
ongoing parasite replication or a permanent change that persisted even after infection subsided. 
Bradyzoites develop following acute infection with the Pru strain of T. gondii and parasite 
reactivation could potentially also account for changes to NK1.1+ NKp46+ cells during chronic 
infection. To test whether ongoing parasite replication played a role, we infected mice with T. 
gondii Pru strain, then suppressed growth of tachyzoites with sulfadiazine at various time points 
post-infection (Eyles and Coleman, 1955). Interestingly, infection induced expansion of ILC1s 
even in sulfadiazine-treated mice when treatment began 7 or 10 days post-infection, with cell 
numbers comparable to those of untreated mice (Figure 24). ILC1 expansion also occurred 
following repeated administration of the Cps1-1 T. gondii strain (Figure 25), which does not 
replicate in vivo and therefore does not persist in a chronic form (Fox and Bzik, 2002). 
Moreover, the number of ILC1s was comparable after infection with Dgra4 parasites on a Pru 
background, which are defective in cyst formation (Fox et al., 2011; Jones et al., 2017), and the 
WT parental strain, PruDku80 (Figure 26). BALB/c mice, which have fewer cysts during chronic 
T. gondii infection (Suzuki et al., 1993), also had increased numbers of ILC1s after infection 
with Pru T. gondii (Figure 27). Thus, T. gondii-induced expansion of ILC1s persists 
independently of ongoing parasite replication. To investigate factors that affect the development 
of these cells, we further examined the impact of infection with the Pru strain of T. gondii. 
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4.2 Effect of Tbet Deficiency 
Tbet is required for ILC1 development (Daussy et al., 2014; Sojka et al., 2014). Moreover, T. 
gondii-induced ILC1s express higher levels of Tbet (Figure 28A), and display increased 
accessibility of the Tbx21 locus (Figure 21B). We therefore hypothesized that Tbet may be 
required for ILC1 expansion after infection. Inasmuch as Tbx21-/- mice succumb to T. gondii 
infection (Harms Pritchard et al., 2015), we studied WT:Tbx21-/- mixed bone marrow chimeras. 
In both uninfected and infected chimeras, cNK cells were present, though they were biased 
towards WT origin (Figure 28B), consistent with a requirement for Tbet for complete cNK cell 
maturation (Gordon et al., 2012). However, no T. gondii-induced ILC1s were found of Tbx21-/- 
origin in infected WT:Tbx21-/- chimeras, like ILC1s in naïve chimeras. Thus, T. gondii-induced 
ILC1s are Tbet-dependent. 
 
Surprisingly, we found that infection increased Tbx21-/- Eomes+ CD49a+ cells in the livers, but 
not the spleens, of WT:Tbx21-/- chimeras, which were also present in counterpart WT cells at 
lower frequencies (Figure 29). Moreover, Eomes+ CD49a+ cells emerged over the course of 
infection in the WT liver (Figure 30) and spleen (Figure 3). This suggested that cNK cells 
upregulate CD49a and subsequently lose Eomes expression. If so, T. gondii-induced ILC1s may 
be cNK cell-derived despite their semblance to ILC1s. 
 
To explore this possibility, we performed single-cell RNA-seq on sorted WT (CD45.1+) or 
Tbx21-/- (CD45.2+) NK1.1+ NKp46+ cells from the livers of uninfected and infected WT:Tbx21-/- 
chimeras. Using t-distributed stochastic neighbor embedding (t-SNE) analysis, we grouped the 
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cells into 17 clusters, C1-C17 (Figure 31A). In the uninfected WT sample, C1 was the largest 
cluster, whereas C1 was diminished in the infected WT and Tbx21-/- samples (Figure 31B-C). C1 
cells expressed Eomes and Itgam but did not express Cd27 or Itga1 (Figure 32). These findings 
are consistent with C1 being mature cNK cells (Figure 31D), which are indeed the predominant 
NK1.1+ NKp46+ cells present in the steady state liver (Figure 33). C3 was the second largest 
cluster in the uninfected WT sample, and C3 cells did not express Eomes or Ly6c2, expressed 
Itga1, Cd27, and Cxcr6, and were absent in Tbx21-/- samples, indicating that C3 comprised 
ILC1s. 
 
C5 and C6 were present in the infected WT sample, but not the uninfected WT sample. These 
cells co-expressed Eomes and Itga1, suggesting that these clusters include the Eomes+ CD49a+ 
cells that arose in the liver after infection (Figures 31-32). These clusters were especially 
prominent in the infected Tbx21-/- sample, confirming that the Eomes+ CD49a+ cells that 
accumulate among Tbx21-/- NK cells resemble cells that typically arise in the WT liver following 
infection. While our current data do not allow definitive association of the Eomes+ CD49a+ cells 
to ILC1s, the single-cell RNA-seq analysis revealed additional subsets of interest. 
 
Two closely related clusters, C10 and C11, were unique to the infected WT sample (Figure 31). 
Cells in C10 and C11 expressed Itga1, Ly6c2, and Klrg1, and did not express Eomes (Figure 32). 
This specificity of infection, Tbet-dependence, and gene expression identified both clusters as T. 
gondii-induced ILC1s (Figure 31D). Interestingly, the presence of two clusters indicated 
heterogeneity within the T. gondii-induced ILC1s population. The t-SNE analysis placed C10 
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closer to mature cNK cells (C1) and C11 closer to ILC1s (C3). Comparison of C10 and C11 
revealed that C10 expressed signature NK cell genes at higher levels (Robinette et al., 2015), 
whereas C11 expressed higher levels of signature ILC1 genes (Figure 34). Interestingly, C10 
also highly expressed Cx3cr1 whereas C11 did not (Figure 32). Indeed, flow cytometric analysis 
confirmed that T. gondii-induced ILC1s in the infected liver contained a CX3CR1+ CXCR6– 
population that expressed higher levels of Zeb2, mirroring the C10 phenotype, and also a 
CX3CR1– CXCR6+ population that mirrors C11 (Figure 35).  
4.3 Requirement of Eomes 
Single-cell RNA-seq analysis revealed heterogeneity of NK1.1+ NKp46+ cells, including within 
T. gondii-induced ILC1s, and raised the possibility that these cells were derived, at least in part, 
from cNK cells. To assess if Eomes downregulation by cNK cells contributed to the ILC1 
population following infection, we examined Ncr1iCre Eomesf/f (Eomes cKO) mice, in which 
NK1.1+ NKp46+ cells were reduced due to the Eomes-dependence of cNK cells (Figure 36), but 
numbers of CD49a+ ILC1s were normal at steady state (Figure 37A) (Gordon et al., 2012; 
Pikovskaya et al., 2016). Following T. gondii infection, the numbers of splenic CD49a+ and 
CD49a+ Ly6C+ cells were significantly reduced in Eomes cKO compared to Eomesf/f controls 
(Figure 37A), showing that expansion of these cells requires Eomes. However, while the overall 
number of CD49a+ cells did not change between uninfected and infected Eomes cKO mice, the 
number of CD49a+ Ly6C+ cells increased slightly, and a greater frequency of the CD49a+ cells 
expressed Ly6C and KLRG1 (Figure 37), showing that ILC1s can also give rise to T. gondii-
induced ILC1s. However, approximately three times as many CD49a+ Ly6C+ were derived from 
Eomes-dependent cells, i.e., cNK cells. These data are consistent with the single-cell RNA-seq 
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data, showing that T. gondii infection results in two closely related populations of T. gondii-
induced ILC1s. 
 
To confirm a cell-intrinsic requirement for Eomes during T. gondii-induced ILC1s expansion, we 
studied NK1.1+ NKp46+ cells in the spleens of mixed bone marrow chimeras reconstituted with 
WT cells and either Eomesf/f or Eomes cKO cells. In uninfected chimeras, the contribution of 
Eomesf/f and Eomes cKO cells to CD49a+ cells was comparable, consistent with these cells being 
Eomes-independent ILC1s (Figure 38). This chimerism did not change upon infection of 
WT:Eomesf/f chimeras. However, infection of WT:Eomes cKO chimeras resulted in a significant 
reduction of CD49a+ cells of Eomes cKO origin. Thus, T. gondii infection resulted in Eomes– 
CD49a+ cells that were dependent on a cell-intrinsic effect of Eomes in NKp46-expressing cells, 
i.e., cNK cells; therefore, most T. gondii-induced ILC1s are ex-cNK cells.  
4.4 Cell-Extrinsic Factors 
We postulated that STAT4 may play a role in the expansion of T. gondii-induced ILC1s because 
STAT4 and IL-12 signaling is critical for NK cell and ILC1 activation during T. gondii infection 
(Cai et al., 2000; Hunter et al., 1994; Klose et al., 2014). To test the relevance of this signaling 
on the generation of T. gondii-induced ILC1s in vivo, we infected WT:Stat4-/- mixed bone 
marrow chimeras. Indeed, STAT4-deficient Eomes– CD49a+ cells were diminished, but not 
absent, while chimerism of cNK cells and ILC1s remained equal between uninfected and 
infected chimeric mice (Figure 39), suggesting that T. gondii-induced ILC1s are dependent on 
STAT4 for development. However, T. gondii-induced ILC1s expansion was not observed in 
cNK cells upon culture of splenocytes from uninfected mice (Figure 40). Moreover, culture of 
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purified cNK cells in IL-12 did not result in Eomes– NK cells, although a small decrease in 
Eomes expression was detected (Figure 41). On the other hand, in vitro culture of splenocytes 
from infected mice resulted in an increased frequency of Eomes– CD49a+ cells following culture 
in IL-2 and IL-12, compared to culture in IL-2 alone (Figure 40), suggesting that IL-12 may 
contribute to expansion of ILC1s. Taken together, these results suggest that STAT4 and IL-12 
contribute to T. gondii-induced ILC1s, but that other factors play additional roles. 
 
Since signaling through TGF-b receptor 2 downregulates Eomes in vitro and in tumors (Cortez et 
al., 2016; Gao et al., 2017), we evaluated Ncr1iCre Tgfbr2f/f mice. After infection, we found 
decreased numbers of ILC1s compared to Tgfbr2f/f mice (Figure 42), consistent with TGF-b 
signaling contributing to T. gondii-induced ILC1 development. However, there were also 
decreased numbers of Eomes+ CD49a– NK cells in infected Ncr1iCre Tgfbr2f/f mice, indicating 
that TGF-b also controls cNK cells more broadly following infection. Thus, TGF-b may act 





Figure 24: Effect of sulfadiazine treatment on development of T. gondii-induced ILC1s 
 
Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from spleens of 
uninfected mice and mice infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain, treated 
with sulfadiazine (SDZ) beginning at indicated dpi, and maintained on sulfadiazine until 35 dpi, 
and frequency and absolute number of ILC1s (n=5-11; mean+SEM; one-way ANOVA with 





Figure 25: Effect of Cps1-1 T. gondii on development of T. gondii-induced ILC1s 
 
(A) Mice were injected with the attenuated Cps1-1 mutant on the type I RH background as shown. 
(B) Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from the spleens of 
uninfected mice and mice administered Cps1-1 T. gondii as in (A), and frequency and absolute 
number of ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) 42 d after initial injection 




Figure 26: Effect of deficient bradyzoite formation on development of T. gondii-induced ILC1s 
 
Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from spleens of mice 35 
dpi with 200 tachyzoites of PruDku80 (WT) T. gondii or PruDku80Dgra4 (Dgra4) T. gondii, and 
frequency and absolute number of ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) (n=8-





Figure 27: Effect of T. gondii infection on T. gondii-induced ILC1 development in BALB/c mice 
Expression of Eomes and CD49a by CD3– CD19– NKp46+ cells from spleens uninfected BALB/c 
mice and BALB/c mice infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain, and 
frequency and absolute number of ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) (n=3; 





Figure 28: Tbet expression and requirement in ILC1s 
 
(A) Expression of Tbet by cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a–) and ILC1s 
(CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from spleens of uninfected mice and mice 
infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain (n=5, mean+SEM; one-way 
ANOVA with Bonferroni correction, ****p £ 0.0001). 
(B) Chimerism of cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a–) and ILC1s (CD3– 
CD19– NK1.1+ NKp46+ Eomes– CD49a+) from spleens of uninfected and infected WT:Tbx21-
/- bone marrow chimeras (n=4-5, mean+SEM; one-way ANOVA with Bonferroni correction, 





Figure 29: Eomes+ CD49a+ cells develop from wild-type and Tbx21-/- NK cells 
 
(A) Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells that are CD45.1-
derived (WT) or CD45.2-derived (Tbx21-/-), from spleens and livers of uninfected and 
infected WT:Tbx21-/- bone marrow chimeras 35 dpi with 200 tachyzoites of T. gondii Pru 
strain. 
(B) Frequency of Eomes+ CD49a+ cells (of CD3 CD19 NK1.1+ NKp46+) in the spleen and liver 
(n=4-7, mean+SEM; one-way ANOVA with Bonferroni correction, ns not significant, *p £ 





Figure 30: Development of Eomes+ CD49a+ cells in the liver during T. gondii infection 
 
(A) Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from livers of mice 
at indicated time points post-infection with 200 tachyzoites of T. gondii Pru strain. 
(B) Frequency and absolute number of CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a+ cells from 
livers of uninfected mice and mice 35 dpi (n=5; mean+SEM; unpaired t-test, ***p £ 0.001, 





Figure 31: Clusters identified by single-cell RNA-seq analysis 
 
(A) Biaxial t-SNE analysis of cells pooled across all samples. Points represent individual cells. 
Colors denote C1-C17. 
(B) t-SNE plots showing the distribution of cells across C1-C17, by sample. 
(C) Fraction of cells in C1-C17, within each sample. 





Figure 32: Gene expression by distinct clusters 
 
(A) Heatmap of average expression of manually selected genes that are characteristic of C1-
C17. 











































































































Figure 33: Quantification of cNK cell and ILC1 populations in the liver by flow cytometry 
 
(A) Expression of CD27 and CD11b by cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49–
) from livers of uninfected mice and mice infected 35 d earlier with 200 tachyzoites of T. 
gondii Pru strain. 
(B) Fraction of CD3– CD19– NK1.1+ NKp46+ cells that belong to each subpopulation in 





Figure 34: Expression of signature ILC1 and cNK cell genes by T. gondii-induced ILC1 
subpopulations 
 
Heatmap of average expression of signature ILC1 and NK cell genes (Robinette et al., 2015), by 




Figure 35: Characterization T. gondii-induced ILC1 subpopulations 
 
(A) Expression of CX3CR1 and CXCR6 by cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ 
CD49a–), and Ly6C– and Ly6C+ ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) from 
livers of mice infected 35 d earlier with 200 tachyzoites of T. gondii Pru strain. 
(B) Expression of Zeb2 by CXCR6+ Ly6C+ ILC1s and CX3CR1+ Ly6C+ ILC1s from the liver of 






Figure 36: Lack of cNK cells in Ncr1iCre Eomesf/f mice 
 
Expression of NK1.1 and NKp46 by CD3– CD19– cells from spleens of Eomesf/f and Eomes cKO 
mice that were uninfected or were infected 35 dpi with 200 tachyzoites of T. gondii Pru strain 






Figure 37: Impaired development T. gondii-induced ILC1s in Ncr1iCre Eomesf/f mice 
 
(A) Expression of Ly6C and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from spleens of 
uninfected and d 35-infected Eomesf/f and Eomes cKO mice, and absolute number of ILC1s 
(CD3– CD19– NK1.1+ NKp46+ CD49a+) and Ly6C+ ILC1s from spleens of uninfected and d 
35-infected Eomesf/f and Eomes cKO mice (n=6-9, mean+SEM; one-way ANOVA with 
Bonferroni correction, ns not significant, *p £ 0.05, ****p £ 0.0001). 
(B) Expression of Ly6C and KLRG1 by CD49a+ cells from the spleens of uninfected and d 35-
infected Eomesf/f and Eomes cKO mice, and frequency of KLRG1+ and Ly6C+ cells (n=6-9, 






Figure 38: Cell intrinsic role of Eomes in development of T. gondii-induced ILC1s 
 
Chimerism of ILC1s (CD3– CD19– NK1.1+ NKp46+ CD49a+) from spleens of uninfected and 35 
d infected WT:Eomesf/f and WT:Eomes cKO bone marrow chimeras (n=4-5, mean+SEM; one-way 





Figure 39: Cell intrinsic role of STAT4 in development of T. gondii-induced ILC1s 
 
Chimerism of cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a–) and ILC1s (CD3– CD19– 
NK1.1+ NKp46+ Eomes– CD49a+) from spleens of uninfected and 35 d infected WT:Stat4-/- bone 
marrow chimeras (n=4-5, mean+SEM; one-way ANOVA with Bonferroni comparison, ns not 





Figure 40: Effect of IL-12 on NK1.1+ NKp46+ cells in vivo 
 
Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from the spleens of 
uninfected mice and mice infected 35 d earlier with T. gondii Pru strain after splenocytes were 
cultured for 36 h in 300 IU/mL IL-2, or 300 U/mL IL-2 + 20 ng/mL IL-12, and frequency of 
ILC1s (n=3-12, mean+SEM; one-way ANOVA with Bonferroni correction, ns not significant, 






Figure 41: Effect of IL-12 on sorted cNK cells and ILC1s 
 
Expression of Eomes and CD49a by sorted cNK cells from uninfected mice and cNK cells and T. 
gondii-induced ILC1s from mice infected 35 d earlier with T. gondii Pru strain, after 36 h of 
culture in IL-2, or IL-2 + IL-12, and frequency of Eomes– CD49a+ NK cells and gMFI of Eomes 
(n=3-9, mean+SEM; one-way ANOVA with Bonferroni correction, ns not significant, **p £ 





Figure 42: Effect of TGF-b signaling on development of T. gondii-induced ILC1s 
 
Expression of Eomes and CD49a by CD3– CD19– NK1.1+ NKp46+ cells from spleens of Tgfbr2f/f 
and Tgfbr2 cKO mice that were uninfected or infected 35 d earlier with T. gondii Pru strain, and 
frequency and absolute number of cNK cells (CD3– CD19– NK1.1+ NKp46+ Eomes+ CD49a–) and 
ILC1s (CD3– CD19– NK1.1+ NKp46+ Eomes– CD49a+) (n=7-11, mean+SEM; unpaired t-test, ns 





Chapter 4: Discussion 
4.1 Overview 
Our analysis initially centered on the comparison of T. gondii-induced ILC1s with both cNK 
cells and ILC1s. RNA-seq showed that T. gondii-induced ILC1s were enriched for an ILC1 gene 
signature and displayed fewer core cNK cells traits, relative to cNK cells. However, although the 
ILC1 gene set was designed to be representative of all ILC1 populations (Robinette et al., 2015), 
some signature ILC1 genes were expressed at lower levels in T. gondii-induced ILC1s. 
Moreover, T. gondii-induced ILC1s uniquely expressed some markers, including Ly6C, KLRG1, 
CD11b, Neuropilin-1, and CX3CR1, compared to both cNK cells and ILC1s. 
 
Whereas most NK1.1+ NKp46+ cells that bear the Eomes– CD49a+ phenotype are tissue-resident 
ILC1s in uninfected mice, we detected T. gondii-induced ILC1s cells in the blood of infected 
mice, where they comprised approximately 20% of NK1.1+ NKp46+ cells. However, T. gondii-
induced ILC1s were enriched for a tissue-residency gene signature and expressed higher levels 
of CD49a, CXCR6, and PECAM-1 and lower levels of CD62L, which are traits of ILC1s that are 
thought to confer tissue-residency. However, in a competitive adoptive transfer setting, we 
observed that ILC1s outcompeted cNK cells in homing to the liver. Thus, T. gondii-induced 
ILC1s circulate freely throughout the vasculature, unlike ordinary ILC1s, but also home 
differently than cNK cells. 
 
T. gondii-induced ILC1s persist even after acute infection resolves, strongly suggesting a 
permanently changed population. This was confirmed by epigenomic analyses, with ATAC-seq 
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revealing sweeping chromatin accessibility differences between T. gondii-induced ILC1s and 
cNK cells. We utilized publicly available ATAC-seq data of cNK cells and ILC1s to determine if 
REs characteristic of ILC1s accounted for the differences we observed. Surprisingly, we found 
many instances of REs that were uniquely more accessible in T. gondii-induced ILC1s. In 
summary, T. gondii-induced ILC1s are distinct from cNK cells and ILC1s in their gene 
expression, circulatory patterns, and epigenetic profile. 
 
Single-cell RNA-seq analysis revealed that T. gondii-induced ILC1s are heterogeneous, with 
activated ILC1s and ex-cNK cells giving rise to two closely related subpopulations that can be 
distinguished from the cNK cells and ILC1s in naïve mice. In contrast to the preexisting notion 
that ILC1s are Eomes-independent, Eomes downregulation results in ex-cNK, which make up 
the majority of T. gondii-induced ILC1s. 
4.2 Significance 
Distinguishing between cNK cells and ILC1s has been challenging since ILC1s were first 
discovered. Initially, liver ILC1s were considered a subset of tissue-resident NK cells. Then, 
cNK cells and ILC1s were categorized together as Group 1 ILCs. Subsequently, the 
identification of a discrete progenitor cell that gives rise to ILC1s and not cNK cells led to the 
current ILC classification system, wherein cNK cells and ILC1s are considered distinct ILC 
subsets. Our findings diverge from the current understanding of these cells by definitively 
showing that cNK cell conversion into ILC1s occurs in T. gondii infection. Our studies indicate 
that the current system of ILC classification, based on their phenotype and development under 
steady state conditions, may not apply following inflammation. Rather, plasticity may give rise 
to populations that resemble one another at first glance, but actually represent the convergence of 
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multiple developmental paths to form interrelated populations. It is possible that the potential for 
plasticity accounts for the confusion surrounding these cell populations. 
 
The only prior observations of Eomes downregulation in cNK cells were made within the tumor 
microenvironment (Gao et al., 2017; Gill et al., 2012) and in vitro (Cortez et al., 2016). Akin to 
the intermediate ILC1s (intILC1s) described within tumors (Gao et al., 2017), we found T. gondii 
infection induced Eomes+ CD49a+ NK cells, which are potential intermediates between NK cells 
and ex-cNK cells. However, our findings differ in several significant ways from intratumoral 
intILC1s. The tumor studies indicated that Eomes– NK cells were restricted to tumors and 
emphasized the importance of the microenvironment (Gao et al., 2017; Gill et al., 2012). These 
considerations led to the interpretation that within tumors, Eomes downregulation transiently 
silences NK cells to hamper immunosurveillance (Silver and Humbles, 2017), since intratumoral 
Eomes– NK cells express high levels of Tigit and display hypofunctionality. By contrast, T. 
gondii-induced ILC1s are disseminated throughout the circulation, retain the ability to produce 
IFNg, do not produce TNFα, and are maintained in the absence of ongoing stimulus. These 
findings suggest a permanent transformation rather than a transient response to inflammation, a 
notion that is further bolstered by the observations that T. gondii-induced ILC1s possess a unique 
gene expression profile that includes increased expression of many transcription factors and 
widespread chromatin remodeling that encompasses many uniquely accessible REs. 
Furthermore, we observed reduced numbers of both cNK cells and ILC1s in Tgfbr2 cKO mice 
following infection, suggesting that TGF-b may have broad effects in T. gondii infection, unlike 
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the aforementioned studies that noted a selective impairment in development of Eomes– NK cells 
from NK cells. 
 
Several factors may account for the reported differences between tumor-induced and T. gondii-
induced Eomes downregulation. First, the reliance on DX5 and CD49a expression to identify NK 
cells and ILC1s may not always faithfully reflect Eomes expression, as is the case during T. 
gondii infection. Second, though there is clear evidence supporting conversion from NK cells to 
intILC1s, the relationship between intILC1s and ILC1s is more tenuous, owing to the inability to 
distinguish between preexisting ILC1s and de novo converted ILC1s. Indeed, this may explain 
discrepancies that currently exist within the field, such as the conflicting report that ILC1-like 
cells confer protection against certain tumors (Dadi et al., 2016). 
 
The persistence of T. gondii-induced ILC1s after clearance of infection is reminiscent of classical 
immune memory and suggests that T. gondii-induced ILC1s play a role beyond what we have 
established for NK cells and ILC1s in T. gondii infection thus far. In T. gondii infection, IL-12 is 
critical for NK cell activation (Gazzinelli et al., 1993) and our data suggest that it can have long-
lasting effects. IL-12 signals through STAT4, which can bind the Tbx21 locus and enhance Tbet 
expression (Madera et al., 2018). Although STAT4 signaling is thought to be important for NK 
cell activation and proliferation during T. gondii infection (Cai et al., 2000), we found cNK cells 
remained intact upon Stat4 deletion, while ILC1s were reduced. This parallels the requirements 
for development of memory and memory-like NK cells induced by MCMV and cytokine 
stimulation (Cooper et al., 2009; Romee et al., 2012; Sun et al., 2012), where IL-12 in the acute 
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setting has durable effects. Future work may reveal a mechanism by which IL-12 signaling 
during acute infection confers long-lasting changes in ILC populations. 
 
MCMV-induced memory NK cells and T. gondii-induced ILC1s share Ly6C expression, IL-12 
dependence, and many epigenetic features (Bezman et al., 2012; Lau et al., 2018). Both cell 
types display alterations in their receptor repertoire, although T. gondii-induced ILC1s primarily 
express the inhibitory receptor NKG2A while MCMV-induced memory NK cells are Ly49H+ 
(Sun et al., 2009a). The epigenetic differences between T. gondii-induced ILC1s and NK cells 
also mirror differences found in human NK cells that do not express FcRg (g–NK cells), which 
display global differences in epigenetic programming and DNA methylation as compared to 
FcRg-expressing NK cells (Lee et al., 2015; Schlums et al., 2015). Interestingly, g–NK cells are 
associated with serological evidence of prior infection with human cytomegalovirus (Guma et 
al., 2004; Guma et al., 2006), suggesting that they are induced by infection. Like g–NK cells, T. 
gondii-induced ILC1s alter their expression of signaling adaptors, lose accessibility at the Zbtb16 
locus and decrease PLZF expression, and change their receptor repertoire.  
4.3 Future Directions 
The rewiring of NK cells and ILC1s that occurs during T. gondii infection may represent an 
actual physiological response, as T. gondii is a natural mouse pathogen. Moreover, mice are 
thought to play important roles as secondary hosts in the T. gondii life cycle as they are prey for 
cats, which are the definitive hosts. Understanding the immune response to T. gondii infection is 
critical, as T. gondii infects humans and can have deleterious impact on immunocompromised 
individuals. Yet much remains unknown about T. gondii infection, especially during chronic 
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infection. The possibility that T. gondii-induced ILC1s contribute to the immune response in 
hitherto unknown ways raises the intriguing prospect of novel therapeutic approaches to treat T. 
gondii infection. Thus, our main focus for future studies involves identifying the role of T. 
gondii-induced ILC1s. 
 
One possible function of T. gondii-induced ILC1s is to circulate and survey for ongoing 
infection. A similar observation was recently main in the ILC2 field. Although ILCs are 
canonically tissue-resident (Gasteiger et al., 2015), ILC2s were recently shown to circulate in 
response to activation by cytokines or infection (Huang et al., 2018). These inflammatory ILC2s 
can be distinguished from tissue-resident ILC2s based on their increased expression of KLRG1 
and S1P receptors, features that are also characteristic of T. gondii-induced ILC1s. Likewise, T. 
gondii-induced ILC1s comprise subpopulations that differ in their expression of CXCR6 and 
CX3CR1. CXCR6 retains ILC1s within hepatic sinusoids, from whence they can mobilize in 
response to contact hypersensitivity and maintain recall responses (Paust et al., 2010; Peng et al., 
2013; Zhang et al., 2016). By contrast, CX3CR1 regulates NK cell recruitment into the 
circulation (Ponzetta et al., 2013; Sciume et al., 2011). Future studies may illuminate that the 
different ILC1 subpopulations have specialized roles, based on their circulatory capacity. 
 
Interestingly, the heterogeneity of T. gondii-induced ILC1s mirrors heterogeneity found among 
CD8+ T cells following activation. Lymphocytic choriomeningitis virus (LCMV) infection 
causes CD8+ T cells to differentiate into diverse subpopulations, and several of these processes 
are guided by the balance between Eomes and Tbet. For instance, Eomes and Tbet interact in a 
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nonredundant and cooperative manner during acute LCMV infection to regulate effector CD8+ T 
cell responses (Pearce et al., 2003). Furthermore, Eomes and Tbet are thought to differentially 
affect virus-specific CD8+ T cells during chronic LCMV infection (Paley et al., 2012). The 
balance of Tbet and Eomes may represent a paradigm that underlies the differentiation processes 
of not only T cells, but rather multiple cell types, including in NK cells during T. gondii 
infection. 
 
Tbet gradients also dictate CD8+ T cell differentiation into either short-lived effector cells or 
memory precursor cells during acute LCMV infection (Joshi et al., 2007). This is process is 
inflammation-dependent, with an important role for IL-12. Moreover, in this setting, Tbet is 
thought to recruit Zeb2 to enhance expression of CX3CR1 and KLRG1 (Dominguez et al., 2015; 
Omilusik et al., 2015). This interaction has already been described in NK cell development (van 
Helden et al., 2015). Taken together, our findings parallel observations made in other fields and 
raise the possibility that common transcriptional networks may operate to give rise to ex-cNK 
cells. Further examination of the role of these transcription factors in T. gondii-induced ILC1s 





Chapter 5: Methods 
5.1 Toxoplasma gondii Infection 
PRU-FLuc-GFP Type II strain of T. gondii was a generous gift from John C. Boothroyd, and 
used in all infections unless otherwise specified. Pru∆ku80∆hx∆gra4::HX/mCherry and the 
wildtype control strain Pru∆ku80∆hx were previously described (Jones et al., 2017). The 
attenuated Cps1-1 mutant on the type I RH background was described previously (Fox and Bzik, 
2002). 
 
All T. gondii strains used in this study were maintained in human foreskin fibroblast (HFF) 
monolayers grown in D-10 medium (Dulbecco’s modified Eagle medium, 10% fetal bovine 
serum (FBS), 2 mM glutamine, 10 mM HEPES pH 7.5, 20 µg/mL gentamicin), maintained at 37 
°C with 5% CO2. The Cps1-1 mutant was grown as described above but supplemented with 200 
µM uracil (Sigma). Mature parasites were lysed from host cells by vigorous pipetting and 
egressed parasites were filtered through 3 µm polycarbonate membranes and resuspended in 
HHE medium (Hanks’ balanced salt solution, 10 mM HEPES, 0.1 mM EGTA). Cell cultures 
were determined to be mycoplasma-negative using the e-Myco plus kit (Intron Biotechnology). 
 
Mice were injected intraperitoneally (i.p.) with 200 PRU-FLuc-GFP, Pru∆ku80∆hx, or 
Pru∆ku80∆hx∆gra4::HX/mCherry tachyzoites that were propagated in culture as described 
above. In indicated experiments, mice were treated with 0.5 g/L sulfadiazine in drinking water to 
suppress parasite growth. To generate non-persistent infections, 1x105 Cps1-1 tachyzoites were 




Eomesf/f, Tbx21-/-, and Stat4-/- were purchased from The Jackson Laboratory. C57BL/6, CD45.1+, 
and BALB/c mice were purchased from Charles River. Ncr1iCre mice were a kind gift from Eric 
Vivier. Zeb2-GFP and Ncr1iCre Tgfbr2f/f mice were previously described (Cortez et al., 2016; Wu 
et al., 2016). Ncr1iCre were bred to Eomesf/f mice to generate Eomes cKO mice and Cre-negative 
littermate controls. Age and sex-matched animals were used in all experiments. Mice were 
infected at 6-12 wk of age. All protocols were approved by the Institutional Animal Care and 
Uses Committee (Washington University School of Medicine, St. Louis, MO) under animal 
protocol number 20160002. 
5.3 Luciferase Imaging 
Mice were injected i.p. with 150 mg D-luciferin (Gold Biotechnology) per kg body weight, 
incubated for 10 min, then anesthetized with continuous isoflurane anesthesia at a flow rate of 1 
L/min. Images were captured using an IVIS Spectrum In Vivo Imaging System (Perkin Elmer). 
Luminescence was quantitated using Living Image software (Perkin Elmer). NK1.1-depleted 
mice were injected i.p. with 100 µg of a-NK1.1, 3 d and 1 d prior to infection. Purified a-NK1.1 
antibody was generated at the Rheumatic Diseases Core Center Protein Purification and 
Production Facility using the PK136 hybridoma (ATCC). 
5.4 Cell Isolation 
Spleens were mashed through a 70 µm cell strainer and treated with Tris-NH4Cl to lyse red 
blood cells. Livers were mashed through a 70 µm cell strainer, resuspended in isotonic 38.5% 
Percoll (Sigma- Aldrich), centrifugated at 325 x g for 20 min, and treated with Tris-NH4Cl. 
Peritoneal cells were isolated by lavage of the peritoneal cavity with PBS. Bone marrow was 
flushed from femurs and tibias, mashed through a 70 µm cell strainer, and treated with Tris-
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NH4Cl. Lymph nodes were mashed through a 70 µm cell strainer. Brains were mashed through a 
70 µm cell strainer, resuspended in 38.5% isotonic Percoll, and centrifugated at 325 x g for 20 
min. Lungs were perfused with PBS, minced, digested in RPMI-1640 containing 2% FBS, 1 
mg/mL Collagenase Type IV (Sigma-Aldrich), and 0.2 mg/mL DNase (Sigma-Aldrich), mashed 
through a 70 µm cell strainer, resuspended in 38.5% isotonic Percoll, and centrifugated at 325 x 
g for 20 min. Uterus and salivary gland were minced, digested in RPMI-1640 containing 0.17 
mg/mL Liberase TL (Sigma-Aldrich) and 0.1 mg/mL DNase (Roche), mashed through a 70 µm 
cell strainer, resuspended in 38.5% isotonic Percoll, and centrifugated at 325 x g for 20 min. 
5.5 Flow Cytometry and Cell Sorting 
Spleens were mashed through a 70 µm cell strainer and treated with Tris-NH4Cl to lyse red 
blood cells. Livers were mashed through a 70 µm cell strainer, resuspended in isotonic 38.5% 
Percoll (Sigma- Aldrich), centrifugated at 325 x g for 20 min, and treated with Tris-NH4Cl. 
Peritoneal cells were isolated by lavage of the peritoneal cavity with PBS. Bone marrow was 
flushed from femurs and tibias, mashed through a 70 µm cell strainer, and treated with Tris-
NH4Cl. Lymph nodes were mashed through a 70 µm cell strainer. Brains were mashed through a 
70 µm cell strainer, resuspended in 38.5% isotonic Percoll, and centrifugated at 325 x g for 20 
min. Lungs were perfused with PBS, minced, digested in RPMI-1640 containing 2% FBS, 1 
mg/mL Collagenase Type IV (Sigma-Aldrich), and 0.2 mg/mL DNase (Sigma-Aldrich), mashed 
through a 70 µm cell strainer, resuspended in 38.5% isotonic Percoll, and centrifugated at 325 x 
g for 20 min. Uterus and salivary gland were minced, digested in RPMI-1640 containing 0.17 
mg/mL Liberase TL (Sigma-Aldrich) and 0.1 mg/mL DNase (Roche), mashed through a 70 µm 
cell strainer, resuspended in 38.5% isotonic Percoll, and centrifugated at 325 x g for 20 min. 
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Cells were stained with Fixable Viability Dye and Fc receptors were blocked with 2.4G2 
hybridoma (ATCC) culture supernatants prior to staining in PBS containing 2% FBS and 2.5 
mM EDTA on ice. Data was acquired using a FACSCanto instrument (BD Biosciences) or 
FACSAria instrument (BD Biosciences) using FACSDiva software (BD Biosciences). Data was 
analyzed with Flowjo v10 (Treestar). 
 
For cell sorting, splenocytes were enriched for NK1.1+ NKp46+ cells by negative selection. 
Splenocytes were incubated with 0.2 µg/mL biotin anti-mouse CD4, 0.2 µg/mL biotin anti-
mouse CD8, and 1 µg/mL biotin anti-mouse CD19. One hundred µL of EasySep Mouse 
Streptavidin Rapidspheres (BD Biosciences) were added per 1x108 splenocytes. Cells were 
placed in an EasySep magnet (BD Biosciences) and enriched cells were poured off, and 
subjected to extracellular staining. Sorting was performed using a FACSAria instrument (BD 
Biosciences) using FACSDiva software (BD Biosciences). cNK cells were identified as live 
CD3– CD19– NK1.1+ NKp46+ Ly6C– CD49a– and T. gondii-induced ILC1s were identified as 
live CD3– CD19– NK1.1+ NKp46+ Ly6C+ CD49a+. 
5.6 Stimulations and Intracellular Staining 
Following extracellular staining, cells were fixed with FoxP3/Transcription Factor Staining 
Buffer Set for 30 min at room temperature and washed with 1x Permeabilization buffer 
(eBiosciences). Transcription factor antibodies were diluted in 1x FoxP3 permeabilization buffer 




To assess Eomes downregulation after culture in IL-12, 5x106 splenocytes were cultured in R-10 
medium (RPMI-1640 medium containing 10% FBS, 2 mM glutamine, 100 U/mL penicillin, and 
100 µg/mL streptomycin) with 300 IU/mL IL-2 with 20 ng/mL IL-12 (Pepro Tech). 
Unstimulated control wells contained only 300 IU/mL IL-2. 
 
For detection of IFNg production, 5x106 splenocytes were cultured for 5 h in R-10, with the 
addition of 20 ng/mL IL-12, 20 ng/mL IL-12 + 5 ng/mL IL-18, or 0.5 µg/mL PMA + 4 µg/mL 
Ionomycin. Brefeldin A was added after 1 h. 
5.7 Generation of Bone Marrow Chimeras 
Donor bone marrow was harvested by flushing femurs and tibias and mashing through a 70 µm 
cell strainer. Cells were mixed in a 1:1 ratio with CD45.1+ bone marrow, and intravenously 
injected into irradiated mice. Recipient mice were lethally irradiated (900 rad) and reconstituted 
with a 1:1 ratio of CD45.1+ bone marrow cells and CD45.2+ Eomes cKO, Eomesf/f, Tbx21-/-, or 
Stat4-/- bone marrow cells (Finotto et al., 2002; Kaplan et al., 1996; Zhu et al., 2010). Mice were 
maintained on sulfamethoxazole/trimethoprim oral suspension added to the drinking water for 2 
wk after reconstitution and used for experiments 6-8 wk after reconstitution. To prevent chimeric 
mice from succumbing to acute T. gondii infection, bone marrow chimeras were treated with 0.5 
g/L sulfadiazine in drinking water beginning 10 d post-infection and maintained on sulfadiazine 
until the end of the experiment. 
5.8 RNA Sequencing 
RNA was isolated from 5x104 sorted cells using Trizol. Libraries were prepared using the 
Clontech SMARTer Kit. Sequencing was performed using 1x50 single-end reads with a 
81 
 
HiSeq3000 instrument (Illumina). Reads were quantified using kallisto and differential 
expression was assessed using the DESeq2 package in R (Bray et al., 2016; Love et al., 2014). 
Using a log2FC cutoff of 1 and an FDR threshold of 0.1, we identified 657 differentially 
expressed (DE) genes between the cNK cells from uninfected and infected mice, 2288 DE genes 
between cNK cells from infected mice and T. gondii-induced ILC1s, and 1685 DE genes 
between cNK cells from uninfected mice and T. gondii-induced ILC1s. Variance-stabilized 
transform values were used for subsequent analysis. All plots were generated in R using the 
ggplot2, pheatmap, and hclust packages. GSEA was performed using the GSEA Preranked 
module in GenePattern (Mootha et al., 2003; Reich et al., 2006; Subramanian et al., 2005). 
5.9 ATAC Sequencing 
Samples were prepared as previously described (Buenrostro et al., 2015), then purified with 
MinElute spin columns (Qiagen). DNA fragments were amplified using Nextera index adapters 
as per manufacturer’s instructions (Illumina). Libraries were purified with AMPure XP beads 
(Beckman Coulter). Three libraries were pooled and sequenced with 2x50 paired end reads using 
a HiSeq3000 instrument (Illumina). 
 
Sequences were aligned to the mm10 reference genome using Bowtie2 (Langmead and Salzberg, 
2012). Reads with a quality score below 30 were removed with Samtools (Li et al., 2009) and 
duplicate reads were filtered with PicardTools (Broad Institute). Peaks were called using 
MACS2 (Zhang et al., 2008) with an FDR cutoff of 0.05. Narrowpeak files generated from 
MACS2 were converted to Bigwig files with deepTools (Ramirez et al., 2014), and visualized 
using the UCSC genome browser. Differential peaks were identified using Homer (Heinz et al., 
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2010) and heatmaps of differentially accessible regions were generated with deepTools. 
Transcription factor binding motifs were identified de novo with Homer. 
 
Across all samples, we identified 71,504 peaks. We further analyzed 9,640 discrete peaks that 
displayed two-fold changes between at least two groups. Between cNK cells from control and 
infected mice, there were 1,809 differential peaks (1445 were larger in the cNK cells from 
infection and 364 were larger in cNK cells from uninfected mice), between cNK cells from 
infected mice and T. gondii-induced ILC1s, there were 6,710 differential peaks (4572 were larger 
in the cNK cells and 2,138 were larger in T. gondii-induced ILC1s), and between cNK cells from 
uninfected mice and T. gondii-induced ILC1s, there were 5,938 differential peaks (3065 were 
larger in the uninfected cNK cells and 2,973 were larger in T. gondii-induced ILC1s). 
5.10 Single-cell RNA Sequencing 
Sorted cells were subjected to droplet-based 3’ end massively parallel single-cell RNA 
sequencing using Chromium Single Cell 3’ Reagent Kits as per manufacturer’s instructions (10x 
Genomics). The libraries were sequenced using a HiSeq3000 instrument (Illumina).  
 
Sample demultiplexing, barcode processing, and single-cell 3’ counting was performed using the 
Cell Ranger Single-Cell Software Suite (10x Genomics). Cellranger count was used to align 





The Seurat package in R was used for subsequent analysis (Butler et al., 2018). Genes expressed 
in fewer than 3 cells and cells that expressed less than 400 or greater than 3500 genes were 
removed for downstream analysis. Data was normalized using a scaling factor of 10,000 and 
nUMI was regressed with a negative binomial model. Principal component analysis was 
performed using the top 3000 most variable genes and t-SNE analysis was performed with the 
top 40 PCAs. Clustering was performed using a resolution of 0.8. For heatmaps, the mean 
expression by all cells within the cluster was used. 
5.11 Quantification and Statistical Analysis 
Prism (GraphPad) was used for statistical analysis. Student’s t-test was used for comparison of 2 
groups and 2-way ANOVA with Bonferroni correction was used in analyses involving multiple 
comparisons. P-values are shown in figures and figure legends. In all graphs, points represent 
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